News Releases
Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
Jul 18, 2022
Prometheus Biosciences Provides Enrollment Update in APOLLO-CD and ARTEMIS-UC Global Phase 2 Studies
Jun 08, 2022
Prometheus Biosciences to Participate at the Jefferies Healthcare Conference
May 26, 2022
Prometheus Biosciences Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress
May 12, 2022
Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Mar 30, 2022
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Progress
Mar 09, 2022
Prometheus Biosciences to Participate at the Cowen 42nd Annual Healthcare Conference
Mar 01, 2022
Prometheus Biosciences to Participate at the 11th Annual SVB Leerink Global Healthcare Conference
Feb 07, 2022
Prometheus Biosciences Provides Corporate Updates at the 40th Annual J.P. Morgan Healthcare Conference
Jan 12, 2022
Prometheus Biosciences to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
Jan 05, 2022
Displaying 11 - 20 of 47